Common use of Laboratory Assessments Clause in Contracts

Laboratory Assessments. Local laboratories will be used for the analysis of scheduled hematology, biochemistry, coagulation, and other tests collected as part of safety monitoring. Screening labs (Table 9) will be performed within 14 days of first dose. Repeat testing on Cycle 1, Day 1 is not required if tests were obtained within 4 days of dosing and are within acceptable ranges. Repeat testing will be performed as outlined in the Schedule of Assessments (Table 2) and as clinically indicated. Note that before each administration of study drug, laboratory results must be reviewed to evaluate for potential toxicity.

Laboratory Assessments. Local laboratories will be used for the analysis of scheduled hematology, biochemistry, coagulation, coagulation and other tests collected as part of safety monitoring. Screening labs (Table 921) will be performed within 14 days of first dose. Repeat testing on Cycle 1, Day 1 is not required if tests were obtained within 4 days of dosing and are within acceptable ranges. Repeat testing will be performed as outlined in the Schedule of Assessments (Table 2, Table 3, and Table 4) and as clinically indicated. Note that before each administration of study drug, laboratory results must be reviewed to evaluate for potential toxicity.